Literature review and expert opinion on the treatment of high-risk acute myeloid leukemia in patients who are eligible for intensive chemotherapy

Literature review and expert opinion on the treatment of high-risk acute myeloid leukemia in patients who are eligible for intensive chemotherapy

In patients with Acute Myeloid Leukemia (AML), the assessment of disease risk plays a central role in the era of personalized medicine. Indeed, integrating baseline clinical and biological features on a case-by-case basis is not only essential to select which treatment would likely result in a highe...

Full description

Bibliographic Details
Main Authors: Raffaele Palmieri, Atto Billio, Felicetto Ferrara, Sara Galimberti, Roberto M. Lemoli, Elisabetta Todisco, Federico Moretti, Adriano Venditti
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-02-01
Series:Frontiers in Oncology
Subjects:
acute myeloid leukemia
clinical prognosticators
disease biology
fitness
acute leukemia
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2024.1367393/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2024.1367393/full

Similar Items